"10.1371_journal.pone.0081004","plos one","2013-11-19T00:00:00Z","Delphine Vandame; Lauriane Ulmann; Marisa Teigell; Monica Prieto-Cappellini; Jacques Vignon; Alain Privat; Regino Perez-Polo; Olivera Nesic; Helene Hirbec","INSERM, U1051, Institut de Neurosciences de Montpellier, Montpellier, France; CNRS, UMR 5203, Institut de Génomique Fonctionnelle, Labex ICST, Montpellier, France; INSERM, U661, Montpellier, France; Universités de Montpellier 1 & 2, UMR5203, Montpellier, France; Neureva, CHU St Eloi, Montpellier, France; Department of Biochemistry & Molecular Biology, UTMB, Galveston, Texas, United States of America; Department of Medical Education, School of Medicine, El Paso, Texas, United States of America","Conceived and designed the experiments: HH RPP AP ON LU DV. Performed the experiments: DV LU MT HH MPC. Analyzed the data: DV HH ON LU AP. Wrote the manuscript: HH ON DV LU JV.","The authors have the following interests. Marisa Teigell and Monica Prieto-Cappellini are employed by Neureva. The GK11 (cis(pip/me)-1-[1-(2-Thienyl)- 2-methylcyclohexyl]piperidine) used in this study was a generous gift from Expansia (France). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","11","Delphine Vandame","DV",9,TRUE,6,5,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
